ArticleCureus2025
Treatment-Resistant Eosinophilic Spongiosis Dermatitis in a Patient With Various Comorbidities: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic spongiosis is a principal term for many diseases that display a histopathology of eosinophilic infiltrates in the spongiotic epidermis. Disorders consistent with eosinophilic spongiosis include autoimmune bullous disorders, chronic eczema, and contact dermatitis. In this case report, we present a 38-year-old male with a generalized, pruritic, and erythematous rash that was diagnosed two years prior as eosinophilic spongiosis and venous stasis dermatitis based on the respective biopsies of the skin of the left elbow and of the right lower extremity. The patient reported intense pruritus that required him to wear white cotton gloves to prevent him from further scratching. His social history was notable for current tobacco use and a past history of illicit drug use. Within the two years, the patient also had numerous appointments with various primary care physicians and cardiology to address his mental health and cardiovascular symptoms such as chest pain, dyspnea, and claudication. Alongside receiving a thorough cardiovascular exam workup, the patient tried numerous treatments for his rash and the pruritus, including topical triamcinolone, tacrolimus ointment, steroid injections, hydroxyzine, amitriptyline, and, most recently, dupilumab therapy. Without much improvement with these therapies, the patient's condition remains persistent and increasingly affects his quality of life. This case report highlights the complexity of ongoing assessment and treatment, offering guidance for the care of patients with similar presentations. Educational insights obtained from this report include maintaining broad differential diagnoses, the influence of neuropsychiatry and cardiology in dermatology, and the importance of multidisciplinary care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.